Kathy J. Carter

1.4k total citations
13 papers, 1.2k citations indexed

About

Kathy J. Carter is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Kathy J. Carter has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Kathy J. Carter's work include Protease and Inhibitor Mechanisms (5 papers), Peptidase Inhibition and Analysis (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Kathy J. Carter is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Peptidase Inhibition and Analysis (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Kathy J. Carter collaborates with scholars based in United States, Japan and Russia. Kathy J. Carter's co-authors include Barbara Fingleton, MacRae F. Linton, Sergio Fazio, Linda A. Gleaves, Vladimir R. Babaev, Lynn M. Matrisian, Clay F. Semenkovich, James B. Atkinson, Alyssa H. Hasty and D. Lee Gorden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Kathy J. Carter

13 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy J. Carter United States 12 468 424 328 307 274 13 1.2k
James X. Rong United States 14 747 1.6× 523 1.2× 600 1.8× 249 0.8× 149 0.5× 18 1.6k
Bernadette Bonardo France 18 212 0.5× 501 1.2× 158 0.5× 199 0.6× 181 0.7× 24 1000
Keyvan Mahboubi United States 15 331 0.7× 700 1.7× 119 0.4× 173 0.6× 284 1.0× 22 1.3k
Alykhan Motani United States 13 217 0.5× 764 1.8× 293 0.9× 218 0.7× 124 0.5× 18 1.5k
Arturo Rosso Italy 24 414 0.9× 918 2.2× 115 0.4× 494 1.6× 293 1.1× 41 1.6k
Eugene Trogan United States 9 1.2k 2.6× 761 1.8× 511 1.6× 299 1.0× 279 1.0× 9 2.1k
Reeni B. Hildebrand Netherlands 25 418 0.9× 808 1.9× 1.2k 3.5× 372 1.2× 473 1.7× 41 1.9k
Jeanny Ohan France 6 416 0.9× 414 1.0× 199 0.6× 111 0.4× 71 0.3× 10 1.0k
Birgit Bossenmaier Germany 19 281 0.6× 807 1.9× 179 0.5× 87 0.3× 816 3.0× 42 1.8k
Peter J. van Santbrink Netherlands 20 639 1.4× 630 1.5× 191 0.6× 111 0.4× 145 0.5× 35 1.2k

Countries citing papers authored by Kathy J. Carter

Since Specialization
Citations

This map shows the geographic impact of Kathy J. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy J. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy J. Carter more than expected).

Fields of papers citing papers by Kathy J. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy J. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy J. Carter. The network helps show where Kathy J. Carter may publish in the future.

Co-authorship network of co-authors of Kathy J. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy J. Carter. A scholar is included among the top collaborators of Kathy J. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy J. Carter. Kathy J. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
VanSaun, Michael N., E. Ashley Dozier, Kathy J. Carter, et al.. (2015). New tools for the quantitative assessment of prodrug delivery and neurotoxicity. NeuroToxicology. 47. 88–98. 4 indexed citations
2.
Carter, Kathy J., et al.. (2014). IL4 Receptor ILR4α Regulates Metastatic Colonization by Mammary Tumors through Multiple Signaling Pathways. Cancer Research. 74(16). 4329–4340. 76 indexed citations
3.
Martin, Michelle D., Kathy J. Carter, Mayland Chang, et al.. (2008). Effect of Ablation or Inhibition of Stromal Matrix Metalloproteinase-9 on Lung Metastasis in a Breast Cancer Model Is Dependent on Genetic Background. Cancer Research. 68(15). 6251–6259. 99 indexed citations
4.
Sinnamon, Mark J., Kathy J. Carter, Barbara Fingleton, & Lynn M. Matrisian. (2008). Matrix metalloproteinase‐9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. International Journal of Experimental Pathology. 89(6). 466–475. 33 indexed citations
5.
Sinnamon, Mark J., et al.. (2008). A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis. 29(4). 880–886. 90 indexed citations
6.
Fingleton, Barbara, Kathy J. Carter, & Lynn M. Matrisian. (2007). Loss of Functional Fas Ligand Enhances Intestinal Tumorigenesis in the Min Mouse Model. Cancer Research. 67(10). 4800–4806. 21 indexed citations
7.
Acuff, Heath B., Kathy J. Carter, Barbara Fingleton, D. Lee Gorden, & Lynn M. Matrisian. (2006). Matrix Metalloproteinase-9 from Bone Marrow–Derived Cells Contributes to Survival but not Growth of Tumor Cells in the Lung Microenvironment. Cancer Research. 66(1). 259–266. 150 indexed citations
8.
Kundranda, Madappa N., Melodie A. Henderson, Kathy J. Carter, et al.. (2005). The Serum Glycoprotein Fetuin-A Promotes Lewis Lung Carcinoma Tumorigenesis via Adhesive-Dependent and Adhesive-Independent Mechanisms. Cancer Research. 65(2). 499–506. 66 indexed citations
9.
Fingleton, Barbara, Ramkumar Menon, Kathy J. Carter, et al.. (2004). Proteinase Activity in Human and Murine Saliva as a Biomarker for Proteinase Inhibitor Efficacy. Clinical Cancer Research. 10(23). 7865–7874. 22 indexed citations
10.
Major, Amy S., Hiroyuki Ishiguro, Yan Ru Su, et al.. (2001). Increased Cholesterol Efflux in Apolipoprotein AI (ApoAI)–Producing Macrophages as a Mechanism for Reduced Atherosclerosis in ApoAI (−/−) Mice. Arteriosclerosis Thrombosis and Vascular Biology. 21(11). 1790–1795. 41 indexed citations
11.
Babaev, Vladimir R., Linda A. Gleaves, Kathy J. Carter, et al.. (2000). Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A. Arteriosclerosis Thrombosis and Vascular Biology. 20(12). 2593–2599. 133 indexed citations
12.
Babaev, Vladimir R., Sergio Fazio, Linda A. Gleaves, et al.. (1999). Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. Journal of Clinical Investigation. 103(12). 1697–1705. 206 indexed citations
13.
Fazio, Sergio, Vladimir R. Babaev, Alyssa H. Hasty, et al.. (1997). Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proceedings of the National Academy of Sciences. 94(9). 4647–4652. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026